Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,965 public trials 1,748 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, Not Recruiting

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

NCT05928416

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Sporadic, Amyotrophic lateral sclerosis 1, +10 more
Locations
  • CHU Strasbourg Strasbourg, Alsace, France
  • CHU Nantes Saint-Herblain, Loire-Atlantique, France
  • C.H.U. de Saint-Étienne Saint-Étienne-de-Montluc, Pays de la Loire Region, France
  • Hospices Civils de Lyon Bron, Rhône, France
View all 19 locations
View Trial Details
Active, Not Recruiting

Study of AV-1959D, an Amyloid Beta Vaccine

NCT05642429

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Banner Alzheimer's Institute Phoenix, Arizona, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of South Florida Tampa, Florida, United States
  • Alzheimer's Research and Treatment Center Wellington, Florida, United States
View Trial Details
Active, Not Recruiting

Multidimensional Assessment of Fatigability in Older Adults Living in Southern Switzerland and Elderly With Parkinson's Disease

NCT07485218

Conditions
Aged 65 Years or Older, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • Neuroimaging Research Unit, Division of Neuroscience San Raffaele Scientific Institute, Vita - Salute San Raffaele University Milan, MI, Italy
  • Multistruttura Sezione Anziani Bellinzona, Canton Ticino, Switzerland
  • University of Applied Sciences and Arts of Southern Switzerland Manno, Canton Ticino, Switzerland
  • Fondazione Parco San Rocco Morbio Inferiore, Canton Ticino, Switzerland
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

NCT04924608

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Research Site Gainesville, Florida, United States
  • Research Site Rockville, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Commack, New York, United States
View all 34 locations
View Trial Details

Related conditions